• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Apixio Launches AI-Powered Solution to Advance Personalized Medicine

by Fred Pennic 09/10/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Apixio Launches AI-Powered Solution to Advance Personalized Medicine

– Quality Identifier uses Apixio’s proprietary AI algorithms to analyze electronic medical record notes, scanned charts, and other patient documents to identify evidence of measure compliance. 


– Algorithm results and supporting evidence are then presented to clinical abstractors for review in a secure web-based application.


– The future of quality measurement in healthcare will be outcomes-oriented, prioritizing quality measures that require patient data from medical documents to supplement claims information. 


Apixio Inc., an AI healthcare analytics company, today announced Quality Identifier, a new solution that allows health plans and providers to unlock critical patient insights for better quality measurement and care delivery. Quality Identifier is delivered as a secure, web-based application for in-house quality measurement teams.

Fastest Way to Find Clinical Facts For Quality Reporting

Quality Identifier leverages Apixio’s proprietary AI algorithms to surface insights from over 10 million patient charts, and analyze clinical data for relevant quality measures and compliance indicators to streamline and accelerate the abstraction process. These facts are presented in an application where abstractors can confirm whether predicted facts demonstrate compliance with relevant measures, significantly reducing the amount of time needed to gather clinical evidence for quality reporting. The result? Much faster chart reviews, more accurate fact-finding, and better progress tracking toward compliance benchmarks.

The Bigger Picture

Federal government agencies are putting increasing pressure on healthcare organizations to deliver higher quality care through robust quality measurement. Currently, most measures designed to determine whether evidence-based care was provided are process-oriented and rely upon coded administrative data. The future of quality measurement in healthcare will be outcomes-oriented, prioritizing quality measures that require patient data from medical documents to supplement claims information. 

Apixio’s proprietary AI algorithms to analyze electronic medical record notes, scanned charts, and other patient documents to identify evidence of measure compliance.  Algorithm results and supporting evidence are then presented to clinical abstractors for review in a secure web-based application.

“It is critical that we’re able to cost-effectively measure performance and adherence to best practices to improve care quality,” said Apixio CEO Darren Schulte, M.D. “With Quality Identifier, providers and plans can gain an accurate picture of care quality without reliance upon large teams of clinicians.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, algorithms, Apixio, electronic medical record, healthcare analytics, Personalized Medicine

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |